本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Achieve Life Sciences, Inc.

2.57
+0.12004.90%
盘后2.770.2000+7.78%18:16 EDT
成交量:16.49万
成交额:41.99万
市值:8,914.06万
市盈率:-2.07
高:2.64
开:2.49
低:2.46
收:2.45
数据加载中...
2021/05/27

持股变动声明

4 - Statement of changes in beneficial ownership of securities
2021/05/25

重要事件披露

8-K - Current report
2021/05/13

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2021/05/13

重要事件披露

8-K - Current report
2021/03/15

重要事件披露

8-K - Current report
2021/03/11

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans
2021/03/11

年度报告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2021/03/11

重要事件披露

8-K - Current report
2021/02/17

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/16

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/16

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/12

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/01/07

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2020/12/04

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2020/11/30

SEC问询函

CORRESP [Cover] - Correspondence
2020/11/30

[补充]招股说明书

FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
2020/11/30

[修订]招股说明书

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
2020/11/13

招股说明书

S-1 - General form for registration of securities under the Securities Act of 1933
2020/11/12

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2020/11/12

重要事件披露

8-K - Current report